Project Grant R03DE036052
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Trustees of Columbia University in the City of New York a Project Grant of $152,166 under the Oral Diseases and Disorders Research program (CFDA 93.121) on September 4, 2026, with completion targeted for September 3, 2029. This award supports research conducted by the Smeeton Lab at Columbia's Health Sciences Division in New York, NY, investigating the lineage capacity and...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded Columbia University's Health Sciences Division a $655,455 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) effective September 11, 2025, with completion targeted for September 10, 2027. This R01 renewal award supports fundamental and translational research to identify temporomandibular joint (TMJ) cartilage progenitor cells and characterize their...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $1,429,422 under the Oral Diseases and Disorders Research program (CFDA 93.121), effective July 1, 2025, with completion targeted for March 31, 2030. This award supports research investigating mechanisms of salivary epithelium-specific expansion following irradiation, addressing a critical clinical challenge in cancer...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Trustees of Columbia University in the City of New York $1,484,592 under the Oral Diseases and Disorders Research program (CFDA 93.121) on August 1, 2025, with a completion date of April 30, 2030. This Project Grant supports the development and validation of a patient-specific TMJ-on-a-chip (TMJOC) model—an integrated bioreactor system designed to investigate multi-tissue interactions...
- Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded a $100,676 Project Grant to Icahn School of Medicine at Mount Sinai beginning December 1, 2025, with completion scheduled for June 30, 2028. This research initiative investigates the functional role of tissue-resident macrophages (TRMs) during salivary gland morphogenesis, addressing a significant gap in understanding how these...
- Federal Grant Award Summary The University of California, Los Angeles received a $449,886 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), effective March 1, 2026 through February 28, 2031. The award funds basic research investigating the regulation of early mandibular morphogenesis by the MSX1 (MSH Homeobox 1) homeobox protein. The research addresses the molecular and cellular mechanisms...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR), under CFDA 93.121 (Oral Diseases and Disorders Research), awarded a $412,500 Project Grant to Massachusetts General Hospital effective August 20, 2025, with completion anticipated by July 31, 2030. The grant funds research into the molecular mechanisms of mutant Isocitrate Dehydrogenase (IDH) inhibition and DNA damage in IDH-mutant glioma. The research leverages a genetically engineered...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Jackson Laboratory a Project Grant totaling $795,730 (awarded March 1, 2026; completion date February 28, 2031) under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant funds research to elucidate the genetic, transcriptional, and histological mechanisms underlying palate morphogenesis using a systems genomics approach in genetically diverse mouse models. The...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Johns Hopkins University a $521,362 Project Grant on August 12, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate neuroimmune interactions in craniofacial bone healing. The research project, which extends through August 11, 2027, seeks to decode the signaling mechanisms between nerves, immune cells, and bone-forming cells during cranial bone repair....
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Columbia University's Health Sciences Division a $660,613 Project Grant effective June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports research investigating spinal cord stimulation (SCS) as a combination therapeutic approach to enhance motor function in patients with spinal muscular atrophy (SMA). The...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $329,000 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) effective June 1, 2026, through May 31, 2028, under the Oral Diseases and Disorders Research program (CFDA 93.121). This research project investigates the genetic characterization of mesencephalic trigeminal nucleus (MESV) sensory cells during normal development and in spinal muscular atrophy (SMA), with particular focus on understanding the sensory-motor circuit mechanisms that govern the developmental transition from suckling to mastication in early postnatal mammals. The research examines how periodontal pressoreceptors and masseter muscle proprioceptive afferents modulate jaw-closing muscle activity through electrical coupling via gap junctions, and how disruption of these connections contributes to orofacial motor deficits in neurodegenerative disease states. The award supports fundamental research designed to elucidate developmental mechanisms governing the maturation of cranial sensory-motor circuits essential for proper feeding behavior and nutrient intake. Given that SMA is the leading genetic cause of infant mortality characterized by motor neuron loss and impaired feeding, findings from this investigation are expected to advance understanding of normal orofacial circuit development while providing insights into the pathophysiological mechanisms underlying feeding difficulties in this severe neurodegenerative condition. The project will be conducted at Columbia University's facility in New York, NY.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $329.0k | 6/1/26 |